| 臺大學術典藏 |
2018 |
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
|
Tzen K.-Y.; Cheng A.-L.; Chen P.-J.; Cheng J.C.-H.; Yang P.-S.; RUOH-FANG YEN; Liu W.-L.; Hsu F.-M.; Tsai C.-L. |
| 國立臺灣大學 |
2016 |
M1a Nodal Involvement and Induction Taxane-Based Chemotherapy Before Neoadjuvant Chemoradiation Therapy Are Associated With Survival Outcomes in Pathological Complete Responder After Trimodality Treatment for Esophageal Squamous Cell Carcinoma
|
Lu, S. L.; Hsu, F. M.; Tsai, C. L.; Lee, J. M.; Huang, P. M.; Hsu, C. H.; Lin, C. C.; Chang, Y. L.; Hsieh, M. S.; Cheng, J. C. H.; 林家齊; 張逸良; 成佳憲; 徐志宏; 謝明書; 李章銘; 黃培銘; 蔡巧琳; 許峰銘 |
| 國立臺灣大學 |
2016 |
Preclinical Study on Radiosensitization by Combining a Novel Drug Lipotecan With Radiation Therapy in Hepatocellular Carcinoma
|
Cheng, J. C. H.; Liu, W. L.; Tsai, C. L.; Hsu, F. M.; 成佳憲; 蔡巧琳; 許峰銘 |
| 臺大學術典藏 |
2016 |
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
|
Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; CHIA-HSIEN CHENG; Hsu F.-M.; Lu S.-L.; Lu S.-L.;Hsu F.-M.;Chen K.-Y.;Ho C.-C.;Yang J.C.-H.;Chia-Hsien Cheng |
| 臺大學術典藏 |
2016 |
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
|
Cheng J.C.-H.;Chih-Hsin Yang;Ho C.-C;Chen K.-Y;Hsu F.-M;Lu S.-L; Lu S.-L; Hsu F.-M; Chen K.-Y; Ho C.-C; CHIH-HSIN YANG; Cheng J.C.-H. |
| 國立臺灣大學 |
2015 |
EGFR Mutation Status Is Associated With Better Radiographic Response and Predicts Favorable Outcomes in Non-Small Cell Lung Cancer Patients With Brain Metastases Treated by Stereotactic Radiosurgery
|
Yang, W. C.; Xiao, F. R.; Shih, J. Y.; Ho, C. C.; Chen, Y. F.; Tseng, H. M.; Chen, K. Y.; Liao, W. Y.; Yu, C. J.; Yang, J. C. H.; Kuo, S. H.; Cheng, J. C. H.; Yang, P. C.; Hsu, F. M.; 曾漢民; 陳雅芳; 楊泮池; 廖唯昱; 郭頌鑫; 陳冠宇; 余忠仁; 成佳憲; 何肇基; 蕭輔仁; 施金元; 許?銘 |
| 臺大學術典藏 |
2015 |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; CHIA-HSIEN CHENG; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.; Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Chia-Hsien Cheng;Wang H.-P.;Yeh K.-H.;Cheng A.-L.;Hsu C.-H. |
| 臺大學術典藏 |
2015 |
Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy
|
Chia-Hsien Cheng J.; Chang D.T.; CHIH-HUNG HSU; Koong A.C.; Lee J.-M.; Huang P.-M.; Wu J.-K.; Tsai C.-L.; Lu S.-L.; Hsu F.-M.; Lu S.-L.;Hsu F.-M.;Tsai C.-L.;Wu J.-K.;Lee J.-M.;Huang P.-M.;Chih-Hung Hsu;Koong A.C.;Chang D.T.;Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2015 |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Guo J.-C.; Huang T.-C.; Lin C.-C.; MIN-SHU HSIEH; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2015 |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang C.-C.;Chia-Hsien Cheng;Tsai C.-L.;Lee J.-M.;Huang P.-M.;Lin C.-C.;Hsu C.-H.;Hsieh M.-S.;Chang Y.-L.;Hsu F.-M.; Wang C.-C.; CHIA-HSIEN CHENG; Tsai C.-L.; Lee J.-M.; Huang P.-M.; Lin C.-C.; Hsu C.-H.; Hsieh M.-S.; Chang Y.-L.; Hsu F.-M. |
